Prospect News: News for NantHealth, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Price: $0.00

Account balance: $0.00

Add to balance / Manage account

User: lxbfYeaa

Log out

Prospect News home > Main news index > All issuers starting with N > Issuers starting with N, CV only > All stories on NantHealth, Inc. > Stories on NantHealth, Inc., CV only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

NantHealth, Inc.

12/16/2016	CV	Market Commentary: New deals in focus; upsized Finisar moves higher in active trade; Amicus slips below par
12/16/2016	CV	Market Commentary: Morning Commentary: New, upsized Finisar moves higher in active trade; new Amicus below par
12/16/2016	CV	New Issue: NantHealth prices $100 million five-year convertibles at 5.5%, up 25%
12/15/2016	CV	Market Commentary: Calendar builds with deals from NantHealth, Amicus, Finisar; notes from Aegean, WWE fizzle
12/15/2016	CV	Market Commentary: Morning Commentary: NantHealth, Amicus Therapeutics in the market; Aegean’s new issue below par
12/15/2016	CV	NantHealth offers $100 million convertible senior notes due 2021; price talk 5%-5.5%, up 25%-30%

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.